Meanwhile, METTL3-modified lncRNA NEAT1 inhibits the progression of chronic myeloid leukemia (CML) by downregulating miR-766-5p targeting cyclin-dependent kinase inhibitor 1A (CDKN1A) [183]. This evidence concerns the gene CDKN1A and chronic myelogenous leukemia, BCR-ABL1 positive.